As Chief Strategy Officer at Germfree, Carol Houts brings nearly three decades of experience in pharmaceutical, biologics product development, quality, regulatory affairs, and clinical research. Her extensive background has positioned her as a strategic force within Germfree, an offsite cleanroom construction company providing innovative facility solutions for biopharmaceutical applications. Carol’s career includes executive leadership roles in various full-service clinical research organizations (CROs) such as QST Consultations (Abond), Clinartis, BioRASI, and Pleiad (Cromsource). Her responsibilities spanned across global service management, including clinical operations, regulatory affairs, pharmacovigilance, and more. She has also held quality and compliance roles at Biomimetic Therapeutics, Stryker Biotech, and Pfizer. Before joining Germfree, Carol had a remarkable track record of enhancing organizations’ capabilities, which translated into increased revenue and long-term growth. Her expertise in leading business development activities to secure funding, along with her prowess in developing business plans that showcased investment opportunities, is a testament to her strategic vision and leadership skills. In her role at Germfree, Carol continues leveraging her industry knowledge and insights to drive growth and success, positioning the company at the forefront of biopharmaceutical facility solutions. Carol takes immense pride in her strong partnership with her husband of over 30 years, with whom she has raised two remarkable children and a tenacious basset hound named Norman. In her leisure time, Carol relishes the great outdoors, engaging in activities such as hiking and kayaking, and appreciating the beauty of mountain life. Her deep-rooted passion for healthcare access and equality serves as a powerful driving force behind her unwavering dedication to the industry she loves and serves.
Chief Strategy Officer